Rickettsial disease is a bacterial infection associated with organisms in the genus Rickettsia [1]. The sources characterize rickettsioses as a diverse group of infections transmitted by arthropods, including tick-borne disease caused by Rickettsia conorii in Mediterranean spotted fever [1][3]. The available material also identifies the broader category as intracellular small Gram-negative bacteria [2].
Disease overview
BacterialRickettsial disease
立克次体病
Rickettsial disease refers to a diverse group of bacterial infections caused by species of the genus Rickettsia and transmitted by arthropods [1][2]. The available sources describe it as a worldwide or tropical travel-associated cause of acute febrile illness, with clinical recognition often based on the combination of fever, headache, rash, and relevant exposure history [1][2]. Source-backed detail is not yet available on a single unified syndrome, because the term encompasses multiple rickettsioses rather than one narrowly defined entity [1][3].
Read the full clinical and epidemiological profile8
The sources describe a typical systemic presentation of acute fever, headache, and skin rash, and in one review a triad of high fever, headache, and skin rash is noted [2][1]. Other reported symptoms include malaise, myalgia, and headache, with an inoculation eschar described as strongly suggestive when present, although it is often absent [1]. Severe, life-threatening complications can occur, but source-backed detail is not yet available on a unified complication pattern across all rickettsial diseases [2][3]. Ocular involvement is reported in the literature cited by one source, with retinitis, retinal vasculitis, and neuroretinitis described as typical findings in rickettsial infection-related uveitis [2].
All age groups are at risk for rickettsial infections during travel to endemic areas, with both short- and long-term travelers at risk for infection [4]. Transmission risk is higher for travelers participating in outdoor activities, those with close proximity to wild or domestic animals, and during periods when vector species feeding activities peak, though infections can occur year-round in many regions [4]. Given an incubation period of 5–10 days for most rickettsial diseases, travelers may develop symptoms during their trip or within 1–2 weeks after returning home [4].
Transmission is described as arthropod-borne, including infection acquired by the bite of contaminated arthropods such as ticks [1][2]. One source specifically characterizes Mediterranean spotted fever as tick-borne [3]. Source-backed detail is not yet available on person-to-person transmission or on the persistence of the organism in specific animal reservoirs for the broader disease group [3].
The sources specifically mention travelers and inhabitants of tropical areas as groups in whom rickettsioses are increasingly recognized [1]. A history of tick bite or exposure is highlighted in the context of Rocky Mountain spotted fever, and acute illness after travel from an endemic area is a key contextual clue [5][1]. Source-backed detail is not yet available on additional demographic or occupational risk groups for the broader disease category.
The source material emphasizes prevention as the mainstay of infection control, but does not provide a detailed prevention schedule or specific protective measures [2]. Because arthropod transmission is central, exposure avoidance to contaminated arthropods is the only directly supported control principle in the provided sources [1][2]. Early clinical suspicion is also highlighted as important for limiting morbidity, since treatment is recommended when the diagnosis is suspected on clinical grounds rather than waiting for serologic confirmation [1][2].
In surveillance and case recognition, rickettsial disease should be considered in a patient with acute febrile illness developing within less than 3 weeks after leaving an endemic area [1]. The combination of fever, headache, and rash, especially with a history of tick bite or other arthropod exposure, is a recurring signal in the sources [1][5][2]. Because antibodies may appear late and clinical differentiation from other febrile illnesses can be difficult, source-backed monitoring should treat the syndrome as an exposure-linked febrile rash illness rather than rely on delayed laboratory confirmation alone [1][2].
- 1Goorhuis A et al. [Rickettsioses]. Ned Tijdschr Geneeskd. 2014. PMID: 24988165.PubMed: https://pubmed.ncbi.nlm.nih.gov/24988165/
- 2Rickettsial disease. Saudi Journal of Ophthalmology. 2022. doi: 10.4103/sjopt.sjopt_86_22.DOI: https://doi.org/10.4103/sjopt.sjopt_86_22
- 3Rovery C et al. Mediterranean spotted fever. Infect Dis Clin North Am. 2008 Sep. PMID: 18755388. doi: 10.1016/j.idc.2008.03.003.PubMed: https://pubmed.ncbi.nlm.nih.gov/18755388/
- 4US Centers for Disease Control and Prevention. Rickettsial Diseases | CDC Yellow Book⢠[Internet]. cited 4 Sept 2026.Available from: https://www.cdc.gov/yellow-book/hcp/travel-associated-infections-diseases/rickettsial-diseases.html
- 5Usatine RP et al. Dermatologic emergencies. Am Fam Physician. 2010 Oct 1. PMID: 20879700.PubMed: https://pubmed.ncbi.nlm.nih.gov/20879700/
- A79
- 1C30
Coverage
Reporting countries and regions
Trends by reporting country
Monthly patterns over time
Data access
Page dataset index with source links and update metadata.
Official sourcesAuthority, cadence, notes1
New Zealand PHF Science Monthly Notifiable Diseases
New Zealand
PHF Science (formerly ESR) monthly notifiable disease surveillance data via internal globalID2 crawler